BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

3084 related articles for article (PubMed ID: 17444126)

  • 1. [Improvement of routine works and quality control in mycobacterial laboratory].
    Suzuki K; Higuchi T
    Kekkaku; 2007 Mar; 82(3):217-27. PubMed ID: 17444126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Mycobacterial tests].
    Takashima T; Higuchi T
    Kekkaku; 2008 Jan; 83(1):43-59. PubMed ID: 18283915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical application of testing methods on acid-fast bacteria].
    Ichiyama S; Suzuki K
    Kekkaku; 2005 Feb; 80(2):95-111. PubMed ID: 15920982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Standardization of laboratory tests for tuberculosis and their proficiency testing].
    Abe C
    Kekkaku; 2003 Aug; 78(8):541-51. PubMed ID: 14509226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Anti-tuberculosis drug resistance survey in Japan, 2002: external quality assessment of results].
    Tuberculosis Research Committee
    Kekkaku; 2007 Mar; 82(3):155-64. PubMed ID: 17444118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [External quality assessment of drug susceptibility testing for Mycobacterium tuberculosis].
    Mitarai S; ;
    Kekkaku; 2006 Aug; 81(8):501-9. PubMed ID: 16972653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Non-tuberculous mycobacteriosis. What has been coming out].
    Kajiki A
    Kekkaku; 2011 Feb; 86(2):113-25. PubMed ID: 21404655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The manual MGIT system for the detection of M. tuberculosis in respiratory specimens: an experience in the University Malaya Medical Centre.
    Fadzilah MN; Ng KP; Ngeow YF
    Malays J Pathol; 2009 Dec; 31(2):93-7. PubMed ID: 20514851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The external quality assessment for Mycobacterium tuberculosis drug susceptibility testing by proficiency testing panel to the commercial laboratories].
    Mitarai S;
    Kekkaku; 2005 Apr; 80(4):349-58. PubMed ID: 15991600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of smear negative pulmonary tuberculosis among patients visiting St. Peter's Tuberculosis Specialized Hospital, Addis Ababa, Ethiopia.
    Desta K; Asrat D; Lemma E; Gebeyehu M; Feleke B
    Ethiop Med J; 2009 Jan; 47(1):17-24. PubMed ID: 19743776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid detection of smear-negative Mycobacterium tuberculosis by PCR and sequencing for rifampin resistance with DNA extracted directly from slides.
    Patnaik M; Liegmann K; Peter JB
    J Clin Microbiol; 2001 Jan; 39(1):51-2. PubMed ID: 11136747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid phenotypic assay of antimycobacterial susceptibility pattern by direct mycobacteria growth indicator tube and phage amplified biological assay compared to BACTEC 460 TB.
    El-Sayed Zaki M; Goda T
    Tuberculosis (Edinb); 2007 Mar; 87(2):102-8. PubMed ID: 17035089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Tuberculosis in compromised hosts].
    Kekkaku; 2003 Nov; 78(11):717-22. PubMed ID: 14672050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Exogenous re-infection in tuberculosis].
    Tsuchiya T
    Kekkaku; 2006 Feb; 81(2):79-91. PubMed ID: 16529009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid mycobacteria drug susceptibility testing using Gel Microdrop (GMD) Growth Assay and flow cytometry.
    Akselband Y; Cabral C; Shapiro DS; McGrath P
    J Microbiol Methods; 2005 Aug; 62(2):181-97. PubMed ID: 16009276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of Mycobacteria Growth Indicator Tube (MGIT) for drug susceptibility testing of Mycobacterium tuberculosis.
    Palomino JC; Traore H; Fissette K; Portaels F
    Int J Tuberc Lung Dis; 1999 Apr; 3(4):344-8. PubMed ID: 10206506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparison of the newly developed MYCOACID system with mycobacteria growth indicator tube (MGIT) and newly developed 2% Ogawa medium (S) for recovery of mycobacteria in clinical specimens].
    Ano H; Yoshida H; Ishida C; Tanigawa N; Kikui M; Takashima T; Tsuyuguchi I
    Kekkaku; 2001 Dec; 76(12):729-39. PubMed ID: 11806129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of BACTEC MGIT 960 system and BACTEC 460 TB system for growth and detection of Mycobacteria from clinical specimens.
    Ganeswrie R; Chui CS; Balan S; Puthucheary SD
    Malays J Pathol; 2004 Dec; 26(2):99-103. PubMed ID: 16329561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 155.